Investigational Treatment ARO-AAT Improves Liver Health in AATD
Interim results from a study on the investigational treatment ARO-AAT showed improvements in multiple measures of liver health, including fibrosis, with a reduction in intrahepatic Z-AAT burden. ARO-AAT is being developed as a treatment for the rare genetic liver disease linked with alpha-1 antitrypsin deficiency (AATD). “The results represent an important breakthrough for the field…
